Diabetes Mellitus, Type 2 Clinical Trials

58 studies are recruiting for diabetes mellitus, type 2 in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 3

  1. The Acute T-Rex (Timing of Resistance Exercise) Study

    The primary aim of this study is to evaluate if a single bout of AM vs PM resistance exercise has different effects on insulin sensitivity and sleep. A randomized cross-over trial be used to compare resistance exercise at two different times of the day. Each condition will take place in a laborator…

    Stage
    Not phased
    Ages
    50 to 74
    Site
    University of Utah HPER E Buildling, Salt Lake City, Utah
    Run by
    University of Utah
  2. NYSCF Scientific Discovery Biobank

    The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store th…

    Stage
    Not phased
    Ages
    0 and older
    Site
    New York Stem Cell Foundation Research Institute, New York, New York
    Run by
    New York Stem Cell Foundation Research Institute
  3. Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)

    The goal of this clinical trial is to learn about the effects of high blood glucose levels in the brain and assess if the changes seen in individuals with poorly control T2DM can be reversed with good glucose control. The main question[s] it aims to answer are: * To determine, whether abnormalities…

    Stage
    Not phased
    Ages
    18 to 60
    Site
    Yale New Haven Hospital (YNHH) Research Unit (HRU), New Haven, Connecticut
    Run by
    Yale University
  4. Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

    The purpose of the study is to evaluate the efficacy of multiple human placental membrane products and Standard of Care (SOC) versus SOC alone in the management of nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) over 12 weeks using a modified platform trial design.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Poirot Podiatry, Metairie, Louisiana
    Run by
    C5 Biomedical
  5. Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance

    This 12-week controlled diet and weight intervention study seeks to define the molecular pathways that link excess body weight to the development of insulin resistance (IR). Blood, adipose and stool are sampled at three timepoints; baseline, peak weight (4 weeks) and post weight loss to monitor cha…

    Stage
    Not phased
    Ages
    35 to 65
    Site
    Stanford University, Stanford, California
    Run by
    Stanford University
  6. PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG

    To evaluate the proportion of diabetic mellitus patients with CV events as measured by HEMOTAG.

    Stage
    Not phased
    Ages
    40 and older
    Site
    Metabolic Research Institute, Inc, West Palm Beach, Florida
    Run by
    Aventusoft, LLC.
  7. Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes

    A human subjects research study, the primary purpose of which is to assess the EFFECTS OF SEMAGLUTIDE ON INTRACRANIAL BLOOD FLOW AND BLOOD-BRAIN BARRIER PERMEABILITY IN TYPE-2 DIABETES (T2D) through testing of the intervention on patients in a clinical setting. The study will randomize subjects wit…

    Stage
    Phase 4
    Ages
    40 to 65
    Site
    University of Washington - Harborview Medical Center, Seattle, Washington
    Run by
    University of Washington
  8. DETERMINE: Detemir vs NPH

    The purpose of the study is to compare rates of neonatal hypoglycemia with maternal NPH vs determir use.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of California, Los Angeles, Los Angeles, California
    Run by
    University of California, Los Angeles

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.